| Characteristics | E. faecalis | E. faecium | Total |
| Total n. (%) | 12 (34.3) | 23 (65.7) | 35 (100.0) |
| Source n. (%) |
|
|
|
| ICU | 5 (14.3) | 6 (17.1) | 11 (31.4) |
| COU | 3 (8.6) | 11 (31.4) | 14 (40.0) |
| Medical Clinic | 3 (8.6) | 2 (5.7) | 5 (14.3) |
| Emergency | 0 (0.0) | 1 (2.9) | 1 (2.9) |
| Cardiology | 1 (2.9) | 3 (8.6) | 4 (11.4) |
| Origin n. (%) |
|
|
|
| Rectal swab | 7 (20.0) | 18 (51.4) | 25 (71.4) |
| Blood | 4 (11.4) | 1 (2.9) | 5 (14.3) |
| Urine | 0 (0.0) | 4 (11.4) | 4 (11.4) |
| Catheter | 1 (2.9) | 0 (0.0) | 1 (2.9) |
| Resistance profile |
|
|
|
| AMP | 1 (2.9) | 21 (60.0) | 22 (62.9) |
| PEN G | 5 (14.3) | 22 (62.8) | 27 (77.1) |
| VAN | 12 (34.3) | 23 (65.7) | 35 (100.0) |
| DAP | 4 (11.4) | 8 (22.9) | 12 (34.3) |
| LIN | 1(2.9) | 4 (11.4) | 5 (14.3) |
| Biofilm formation n. (%) |
|
|
|
| Strong biofilm on hydrophobic substrate | 10 (28.6) | 7 (20.0) | 17 (48.6) |
| Strong biofilm on hydrophilic substrate | 2 (5.7) | 0 (0.0) | 2 (5.7) |
| Strong TSB biofilm | 9 (25.7) | 4 (11.4) | 13 (37.1) |
| Strong BHI biofilm | 5 (14.3) | 4 (11.4) | 9 (25.7) |
| Cellular hydrophobicity n. (%) |
|
|
|
| HFL | 2 (5.7) | 22 (62.9) | 24 (68.6) |
| M HFB | 9 (25.7) | 1 (2.9) | 10 (28.6) |
| HFB | 1 (2.9) | 0 (0.0) | 1 (2.9) |
| Virulence genes n. (%) |
|
|
|
| gelE | 2 (5.7) | 17 (48.6) | 19 (54.3) |
| esp | 2 (5.7) | 17 (48.6) | 19 (54.3) |
| asa1 | 7 (20.0) | 1 (2.9) | 8 (22.9) |